Rate of Incidental Pathological Lesions ın Reduction Mammoplasty Specimens and Incidence of Invasive Breast Carcinoma Following Breast Reduction Operation.

Aesthetic plastic surgery 2022 Vol.46(1) p. 83-90

Nergiz D, Süren D, Alikanoğlu AS, Yıldırım HT, Altun ZA, Uslu A

관련 도메인

Abstract

[INTRODUCTION] Reduction mammoplasty (RM) is one of the most frequently performed surgical procedures. The incidental determination of significant pathologic lesions (SPL), that is precursor and malignant lesions, in RM specimens is rare. The aim of this study was to determine the frequency of SPL in RM specimens, to evaluate the relationship between SPL and clinicopathological factors, and to examine the incidence of invasive breast carcinoma forming in the remaining breast tissue during the postoperative follow-up period developing in patients after RM operation.

[MATERIAL AND METHOD] This retrospective study included 874 females who underwent RM operation between January 2012 and January 2021. Demographic, clinicopathological findings, and preoperative radiological findings were recorded. The patients were followed up after the RM operation in respect of the first occurrence of breast cancer.

[RESULTS] Invasive carcinoma was determined in 0.2% and SPL in 3.5% in RM. The probability of SPL determination was greater in patients aged ≥ 40 years and with ≥ 4 paraffin blocks (p=0.038, p=0.01, respectively). No statistically significant difference was found between patients with and without SPL in respect of radiological findings (p=0.35). The mean postoperative follow-up period was 53.6 months, and invasive carcinoma was diagnosed during follow-up in 0.2% of all patients (6.9% of the patients with SPL).

[CONCLUSION] Age over 40 years and an increased number of sampled blocks were found to be factors increasing the possibility of the determination of precursor and malignant lesions in RM specimens. RM could decrease the risk of the development of breast cancer.

[LEVEL OF EVIDENCE IV] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 6
시술 reduction mammoplasty 유방성형술 dict 2
시술 breast reduction 유방성형술 dict 1
해부 Specimens scispacy 1
약물 [INTRODUCTION] Reduction mammoplasty scispacy 1
약물 [MATERIAL AND scispacy 1
약물 [RESULTS] Invasive carcinoma scispacy 1
질환 Breast Carcinoma C0678222
Breast Carcinoma
scispacy 1
질환 breast cancer C0006142
Malignant neoplasm of breast
scispacy 1
질환 carcinoma C0007097
Carcinoma
scispacy 1
질환 Invasive Breast Carcinoma scispacy 1
질환 malignant lesions scispacy 1
질환 RM specimens scispacy 1
질환 breast tissue scispacy 1
기타 patients → patients with SPL scispacy 1

MeSH Terms

Adult; Breast; Breast Neoplasms; Female; Humans; Incidence; Mammaplasty; Retrospective Studies; Treatment Outcome

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문